NCT06601140View on ClinicalTrials.gov

Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Moderate Depressive Episode

NARecruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

March 5, 2025

Primary Completion Date

November 4, 2025

Study Completion Date

November 4, 2025

Conditions
Major Depressive Disorder (MDD)
Interventions
DEVICE

EMOCARE software

Use of the EMOCARE software on the digital device of participant (smartphone, computer, etc.). The participant can activate and deactivate the software whenever he wishes.

Trial Locations (7)

35000

RECRUITING

Centre hospitalier Guillaume Régnier, Rennes

35760

RECRUITING

Private psychiatric practice, Saint-Grégoire

44000

RECRUITING

Private psychiatric practice, Nantes

44093

NOT_YET_RECRUITING

Centre Hospitalier Universitaire de Nantes, Nantes

44600

RECRUITING

Private psychiatric practice, Saint-Nazaire

54320

TERMINATED

Private psychiatric practice, Maxéville

54521

NOT_YET_RECRUITING

Centre Psychothérapique de Nancy, Laxou

Sponsors

Lead Sponsor

Emobot
All Listed Sponsors
collaborator

Rumb

UNKNOWN

collaborator

Nantes University Hospital

OTHER

collaborator

Private psychiatric practice, Saint-Nazaire

UNKNOWN

collaborator

Groupement Hospitalier Paul Guiraud, Villejuif

UNKNOWN

collaborator

Centre Hospitalier Guillaume Régnier, RENNES

UNKNOWN

collaborator

Centre de Psychothérapie Nancéen, Laxou

UNKNOWN

lead

Emobot

INDUSTRY

NCT06601140 - Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Moderate Depressive Episode | Biotech Hunter | Biotech Hunter